Horizon 2020 - PERSONALISED MEDICINE - H2020-SC1-2016-2017

Bando H2020-SC1-2016-2017 nell'ambito del programma Ue per la ricerca e l'innovazione Horizon 2020. L'invito prevede i seguenti argomenti (topic): SC1-HCO-01-2016:Valorisation of FP7 Health and H2020 SC1 research results SC1-HCO-02-2016:Standardisation of pre-analytical and analytical procedures for in vitro diagnostics in personalised medicine SC1-HCO-03-2017:Implementing the Strategic Research Agenda on Personalised Medicine SC1-HCO-04-2016:Towards globalisation of the Joint Programming Initiative on Antimicrobial resistance SC1-HCO-05-2016:Coordinating personalised medicine research SC1-HCO-06-2016:Towards an ERA-NET for building sustainable and resilient health system models SC1-HCO-07-2017:Global Alliance for Chronic Diseases (GACD) SC1-HCO-08-2017:Actions to bridge the divide in European health research and innovation SC1-HCO-10-2016:Support for Europe’s leading Health ICT SMEs SC1-HCO-11-2016:Coordinated action to support the recognition of Silver Economy opportunities arising from demographic change SC1-HCO-12-2016:Digital health literacy SC1-HCO-13-2016:Healthcare Workforce IT skills SC1-HCO-14-2016:EU-US interoperability roadmap SC1-HCO-15-2016:EU eHealth Interoperability conformity assessment SC1-HCO-16-2016:Standardisation needs in the field of ICT for Active and Healthy Ageing SC1-PM-01-2016:Multi omics for personalised therapies addressing diseases of the immune system SC1-PM-02-2017:New concepts in patient stratification SC1-PM-03-2017:Diagnostic characterisation of rare diseases SC1-PM-04-2016:Networking and optimising the use of population and patient cohorts at EU level SC1-PM-05-2016:The European Human Biomonitoring Initiative SC1-PM-06-2016:Vaccine development for malaria and/or neglected infectious diseases SC1-PM-07-2017:Promoting mental health and well-being in the young SC1-PM-08-2017:New therapies for rare diseases...